Enliven Therapeutics, Inc. (NASDAQ:ELVN – Get Free Report) insider Joseph P. Lyssikatos sold 2,707 shares of Enliven Therapeutics stock in a transaction on Monday, October 7th. The shares were sold at an average price of $27.61, for a total value of $74,740.27. Following the transaction, the…
